Literature DB >> 30990092

The role of adipokines in the pathogenesis of gestational diabetes mellitus.

G de Gennaro1, G Palla1, L Battini2, T Simoncini1, S Del Prato1, A Bertolotto3, C Bianchi3.   

Abstract

Gestational diabetes mellitus (GDM) is a complex condition whose physiopathology to date has not been completely clarified. Two major metabolic disorders, insulin resistance and β-cells dysfunction, play currently major role in pathogenesis of GDM. These elements are influenced by the amount of adipose tissue present before and/or during the pregnancy. Consequently, adipokines (adiponectin (APN), leptin (LPT), adipocyte fatty acid-binding protein, resistin, visfatin, omentin, vaspin, apelin, chemerin) secreted by adipose tissue, may contribute directly and/or indirectly, through the enhancement of chronic inflammation, aggravating insulin resistance and promoting GDM onset. This review aims to outline the potential physiopathological and prognostic role in GDM of adipokines, mainly APN and LPT.

Entities:  

Keywords:  Adipokine; adiponectin; gestational diabetes; insulin resistance; insulin sensitivity; leptin

Year:  2019        PMID: 30990092     DOI: 10.1080/09513590.2019.1597346

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  17 in total

1.  Association between omentin-1 and indices of glucose metabolism in early pregnancy: a pilot study.

Authors:  Stefania Papatheodorou; Bizu Gelaye; Michelle A Williams
Journal:  Arch Gynecol Obstet       Date:  2021-08-24       Impact factor: 2.344

2.  Circulating apelin, chemerin and omentin levels in patients with gestational diabetes mellitus: a systematic review and meta-analysis.

Authors:  Jianran Sun; Jiale Ren; Chunlin Zuo; Datong Deng; Faming Pan; Ruoping Chen; Jie Zhu; Chao Chen; Shandong Ye
Journal:  Lipids Health Dis       Date:  2020-02-22       Impact factor: 3.876

3.  Knowledge, attitude, and practice of patients with type 2 diabetes mellitus with regard to their disease: a cross-sectional study among Palestinians of the West Bank.

Authors:  Ramzi Shawahna; Saed Samaro; Zaid Ahmad
Journal:  BMC Public Health       Date:  2021-03-09       Impact factor: 3.295

4.  D-Chiro-Inositol Regulates Insulin Signaling in Human Adipocytes.

Authors:  Maria Magdalena Montt-Guevara; Michele Finiguerra; Ilaria Marzi; Tiziana Fidecicchi; Amerigo Ferrari; Alessandro D Genazzani; Tommaso Simoncini
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-30       Impact factor: 5.555

5.  Proteomics Analysis of Serum Proteins in Gestational Diabetes.

Authors:  Jianhua Li; Lin Lu; Xinping Xie; Xiaofeng Dai; Shan Zheng; Lihong Chen
Journal:  Evid Based Complement Alternat Med       Date:  2021-11-02       Impact factor: 2.629

Review 6.  Novel Biomolecules in the Pathogenesis of Gestational Diabetes Mellitus.

Authors:  Monika Ruszała; Magdalena Niebrzydowska; Aleksandra Pilszyk; Żaneta Kimber-Trojnar; Marcin Trojnar; Bożena Leszczyńska-Gorzelak
Journal:  Int J Mol Sci       Date:  2021-10-27       Impact factor: 5.923

7.  C1q/tumor necrosis factor related protein 6 (CTRP6) regulates the phenotypes of high glucose-induced gestational trophoblast cells via peroxisome proliferator-activated receptor gamma (PPARγ) signaling.

Authors:  Jin Zhang; Wen-Pei Bai
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

8.  Whole transcriptome expression profiles in placenta samples from women with gestational diabetes mellitus.

Authors:  Lei Tang; Ping Li; Ling Li
Journal:  J Diabetes Investig       Date:  2020-05-13       Impact factor: 4.232

9.  Expression and correlation of Chemerin and FABP4 in peripheral blood of gestational diabetes mellitus patients.

Authors:  Xueling Wang; Juanjuan Liu; Dongqing Wang; Honghua Zhu; Le Kang; Juan Jiang
Journal:  Exp Ther Med       Date:  2019-11-26       Impact factor: 2.447

10.  Serum C18:1-Cer as a Potential Biomarker for Early Detection of Gestational Diabetes.

Authors:  Ilona Juchnicka; Mariusz Kuźmicki; Piotr Zabielski; Adam Krętowski; Agnieszka Błachnio-Zabielska; Jacek Szamatowicz
Journal:  J Clin Med       Date:  2022-01-13       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.